Login / Signup

Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.

Luca LiberaleFabrizio MontecuccoIlaria CasettaSilva SeraceniAlessandro TrentiniMarina PadroniFranco DallegriFrançois MachEnrico FainardiFederico Carbone
Published in: European journal of clinical investigation (2016)
A decrease in PCSK9 levels was a predictor for poor outcome and increased MACEs after AIS. Additional studies targeting post-AIS PCSK9 levels and activity are required to clarify the prognostic and pathophysiological relevance of PCSK9 after AIS.
Keyphrases
  • low density lipoprotein
  • metabolic syndrome
  • type diabetes
  • cancer therapy
  • glycemic control